Document is current
Any future updates will be listed below
-
Authors
Gregg, Edward W.
Holman, Naomi
Sophiea, Marisa
Misra, Shivani
Pearson-Stuttard, Jonathan
Valabhji, Jonathan https://orcid.org/0000-0001-9756-4061
Khunti, Kamlesh
-
Funding
Funding for this research was provided by:
Science Foundation Ireland (22/RP/10091)
- License Information
-
More Information
Article History
Received: 20 July 2023
Accepted: 15 January 2025
First Online: 14 February 2025
Competing interests
: S.M. has received speaker Honoraria from Lilly and Sanofi, UK. K.K. has acted as a consultant, speaker or received grants for investigator-initiated studies for Astra Zeneca, Bayer, Novo Nordisk, Sanofi-Aventis, Servier, Lilly and Merck Sharp & Dohme, Boehringer Ingelheim, Oramed Pharmaceuticals, Pfizer, Roche, Daiichi-Sankyo, Applied Therapeutics, Embecta and Nestle Health Science. J.P.S. is a Partner at Lane Clark & Peacock LLP and Chair of the Royal Society for Public Health and reports consultancy fees from Novo Nordisk outside of this work. J.V. was the National Clinical Director for Diabetes and Obesity at NHS England from April 2013 to September 2023 and currently is the National Clinical Lead for Multiple Long Term Conditions at NHS England.
